Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

Por Hirata, T, Shimizu, C, Yonemori, K, Hirakawa, A, Kouno, T, Tamura, K, Ando, M, Katsumata, N, Fujiwara, Y
Publicado em 2009

Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.

Por Yonemori, K., Imamura, T., Ishidou, Y., Okano, T., Matsunaga, S., Yoshida, H., Kato, M., Sampath, T. K., Miyazono, K., ten Dijke, P., Sakou, T.
Publicado em 1997

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

Por Tanioka, M, Shimizu, C, Yonemori, K, Yoshimura, K, Tamura, K, Kouno, T, Ando, M, Katsumata, N, Tsuda, H, Kinoshita, T, Fujiwara, Y
Publicado em 2010

Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Por Taniyama, T.K., Hashimoto, K., Katsumata, N., Hirakawa, A., Yonemori, K., Yunokawa, M., Shimizu, C., Tamura, K., Ando, M., Fujiwara, Y.
Publicado em 2014

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

Por Yonemori, K, Ando, M, Yunokawa, M, Hirata, T, Kouno, T, Shimizu, C, Tamura, K, Katsumata, N, Hirakawa, A, Matsumoto, K, Yamanaka, Y, Arioka, H, Fujiwara, Y
Publicado em 2009

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies

Por Okuma, H S, Koizumi, F, Hirakawa, A, Nakatochi, M, Komori, O, Hashimoto, J, Kodaira, M, Yunokawa, M, Yamamoto, H, Yonemori, K, Shimizu, C, Fujiwara, Y, Tamura, K
Publicado no Br J Cancer (2016)